UnityPoint Health Ventures has made its third play, backing St. Louis-based Epharmix, a remote patient monitoring technology company, with a $1 million investment. Unveiled in May of this year, UnityPoint Health Ventures awards investments to early-stage companies in four key areas: digital health, medical devices, health care technology systems and health care services. The fund supports companies whose technology can be used across the UnityPoint Health system, which includes 22 hospitals and 18 affiliates in Iowa, Illinois and Wisconsin.